<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>DynamicPatents:  Patent News, Reviews and Marketplace &#187; Dey L.P.</title>
	<atom:link href="http://www.dynamicpatents.com/tag/dey-lp/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.dynamicpatents.com</link>
	<description></description>
	<lastBuildDate>Tue, 10 Nov 2009 17:22:19 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Mylan Inc. Issued Patents for COPD</title>
		<link>http://www.dynamicpatents.com/2009/01/mylan-issued-patents-copd/</link>
		<comments>http://www.dynamicpatents.com/2009/01/mylan-issued-patents-copd/#comments</comments>
		<pubDate>Mon, 12 Jan 2009 16:34:46 +0000</pubDate>
		<dc:creator>Alex</dc:creator>
				<category><![CDATA[New Patents]]></category>
		<category><![CDATA[Dey L.P.]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[Mylan Inc.]]></category>
		<category><![CDATA[notice of allowance]]></category>
		<category><![CDATA[patent application]]></category>
		<category><![CDATA[patent pending]]></category>

		<guid isPermaLink="false">http://www.dynamicpatents.com/?p=631</guid>
		<description><![CDATA[Mylan Inc. announced this morning that they have been issued several U.S. patents which cover the administration of a ready-to-use inhaler.  Mylan stated in a press release that the patents were directly granted to its subsidiary, Dey L.P., and that the company received a &#8220;Notice of Allowance&#8221; on another patent which they expect to be granted [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://dynamicpatents.com/blog/wp-content/uploads/copd.jpg"><img class="alignright size-full wp-image-632" title="copd" src="http://dynamicpatents.com/blog/wp-content/uploads/copd.jpg" alt="copd" width="285" height="320" /></a>Mylan Inc. announced this morning that they have been issued several U.S. patents which cover the administration of a ready-to-use inhaler.  Mylan stated in a <a href="http://news.prnewswire.com/DisplayReleaseContent.aspx?ACCT=104&amp;STORY=/www/story/01-12-2009/0004952887&amp;EDATE=" target="_blank">press release</a> that the patents were directly granted to its subsidiary, Dey L.P., and that the company received a &#8220;Notice of Allowance&#8221; on another patent which they expect to be granted in the near future.</p>
<p>The issued patents protect Dey&#8217;s Perforomist Inhalation Solution, which is a treatment for chronic obstructive pulmonary disease.  Two of the patents are directed towards the compositions of &#8220;R-formoterol,&#8221; a specific form of the formoterol molecule, and its use.  Another patent covers the administration of formoterol in a storage stable composition.  These patents extend to the year 2021.</p>
<p>Once the patent is granted that received a &#8220;Notice of Allowance,&#8221; Dey will possess seven patents directed towards the composition and use of formoterol.  Dey also has additional patents pending directed to formoterol-containing compositions and their use in the treatment of respiratory conditions.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.dynamicpatents.com/2009/01/mylan-issued-patents-copd/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
